|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2009-7-17
|
|
pubmed:abstractText |
It remains unclear whether U50488H (a selective kappa-opioid receptor agonist) produces anti-apoptotic effect during ischemia and reperfusion (I/R). Therefore, the effect of U50488H on myocardial apoptosis was investigated in the present study.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/3,4-Dichloro-N-methyl-N-(2-(1-pyrrol...,
http://linkedlifedata.com/resource/pubmed/chemical/Antihypertensive Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Caspase 3,
http://linkedlifedata.com/resource/pubmed/chemical/Caspase 9,
http://linkedlifedata.com/resource/pubmed/chemical/Naltrexone,
http://linkedlifedata.com/resource/pubmed/chemical/Narcotic Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-bcl-2,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Opioid, kappa,
http://linkedlifedata.com/resource/pubmed/chemical/bcl-2-Associated X Protein,
http://linkedlifedata.com/resource/pubmed/chemical/norbinaltorphimine
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1873-5487
|
|
pubmed:author |
pubmed-author:ChenTaoT,
pubmed-author:ChengLiangL,
pubmed-author:CuiQinQ,
pubmed-author:FanRongR,
pubmed-author:FreBB,
pubmed-author:GuChun-HuCH,
pubmed-author:GuoHai-TaoHT,
pubmed-author:PeiJian-MingJM,
pubmed-author:Shu-MiaoZhangZ,
pubmed-author:WangYue-MinYM,
pubmed-author:YeMing-XiangMX,
pubmed-author:YiDing-HuaDH,
pubmed-author:YuShi-QiangSQ,
pubmed-author:ZhangPengP,
pubmed-author:ZhangQuan-YuQY,
pubmed-author:ZhaoYinY
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
40
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
227-34
|
|
pubmed:dateRevised |
2010-5-3
|
|
pubmed:meshHeading |
pubmed-meshheading:19608010-3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-ben...,
pubmed-meshheading:19608010-Animals,
pubmed-meshheading:19608010-Antihypertensive Agents,
pubmed-meshheading:19608010-Apoptosis,
pubmed-meshheading:19608010-Caspase 3,
pubmed-meshheading:19608010-Caspase 9,
pubmed-meshheading:19608010-DNA Fragmentation,
pubmed-meshheading:19608010-Male,
pubmed-meshheading:19608010-Microscopy, Electron, Transmission,
pubmed-meshheading:19608010-Myocardial Infarction,
pubmed-meshheading:19608010-Myocardium,
pubmed-meshheading:19608010-Naltrexone,
pubmed-meshheading:19608010-Narcotic Antagonists,
pubmed-meshheading:19608010-Proto-Oncogene Proteins c-bcl-2,
pubmed-meshheading:19608010-Rats,
pubmed-meshheading:19608010-Rats, Sprague-Dawley,
pubmed-meshheading:19608010-Receptors, Opioid, kappa,
pubmed-meshheading:19608010-Reperfusion Injury,
pubmed-meshheading:19608010-bcl-2-Associated X Protein
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Myocardial apoptosis and infarction after ischemia/reperfusion are attenuated by kappa-opioid receptor agonist.
|
|
pubmed:affiliation |
Department of Physiology, National Key Discipline of Cell Biology, Xijing Hospital, Fourth Military Medical University, Shaanxi Province, PR China.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
